Merck drug to reverse anesthesia delayed again at FDA
WASHINGTON (Reuters) - U.S. health regulators need more time to review Merck & Co's application to sell sugammadex, an injection designed to reverse t...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/BnBLCiNmxLM/story01.htm
No comments:
Post a Comment